These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 2834002

  • 21. Sucrose drinking reduces dorsal hypothalamic beta-endorphin levels in spontaneously hypertensive rats but not in Wistar-Kyoto rats.
    Zhang T, Rockhold RW.
    Brain Res Bull; 1993; 32(3):261-5. PubMed ID: 8374805
    [Abstract] [Full Text] [Related]

  • 22. Age-dependent hyperresponsiveness of spontaneously hypertensive rats to the pressor effects of intravenous neuropeptide Y (NPY): role of mode of peptide administration and plasma NPY-like immunoreactivity.
    Miller DW, Tessel RE.
    J Cardiovasc Pharmacol; 1991 Nov; 18(5):647-56. PubMed ID: 1723760
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Corticotropin-releasing factor: actions on the sympathetic nervous system and metabolism.
    Brown MR, Fisher LA, Spiess J, Rivier C, Rivier J, Vale W.
    Endocrinology; 1982 Sep; 111(3):928-31. PubMed ID: 7049676
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Reduction in brain immunoreactive corticotropin-releasing factor (CRF) in spontaneously hypertensive rats.
    Hashimoto K, Hattori T, Murakami K, Suemaru S, Kawada Y, Kageyama J, Ota Z.
    Life Sci; 1985 Feb 18; 36(7):643-7. PubMed ID: 3871498
    [Abstract] [Full Text] [Related]

  • 27. The effects of naloxone on the cardiovascular and respiratory effects of centrally administered corticotrophin releasing factor in conscious rabbits.
    May CN, Whitehead CJ, Mathias CJ.
    Br J Pharmacol; 1991 Jul 18; 103(3):1776-80. PubMed ID: 1933140
    [Abstract] [Full Text] [Related]

  • 28. Chronic intracerebroventricular CRF infusion attenuates ACTH-corticosterone release.
    Cunningham JJ, Meara PA, Lee RY, Bode HH.
    Am J Physiol; 1988 Aug 18; 255(2 Pt 1):E213-7. PubMed ID: 2841865
    [Abstract] [Full Text] [Related]

  • 29. Comparison of the biologic actions of corticotropin-releasing factor and sauvagine.
    Brown MR, Fisher LA, Spiess J, Rivier J, Rivier C, Vale W.
    Regul Pept; 1982 Jul 18; 4(2):107-14. PubMed ID: 6289384
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Brain corticotropin releasing factor in the spontaneously hypertensive rat.
    Hattori T, Hashimoto K, Ota Z.
    Hypertension; 1986 Nov 18; 8(11):1027-31. PubMed ID: 3490439
    [Abstract] [Full Text] [Related]

  • 33. Central actions of corticotropin releasing factor on sensori-autonomic processing in normotensive and hypertensive rats.
    Youngblood K, Conti L, Printz MP.
    Brain Res; 1996 Sep 23; 734(1-2):175-85. PubMed ID: 8896823
    [Abstract] [Full Text] [Related]

  • 34. Central effect of aprotinin, a serine protease inhibitor, on blood pressure in spontaneously hypertensive and Wistar-Kyoto rats.
    Seto S, Akahoshi M, Kusano S, Kitamura S, Hashiba K.
    Adv Exp Med Biol; 1989 Sep 23; 247B():49-54. PubMed ID: 2481949
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Correlation between brain bradykinin receptor binding sites and cardiovascular function in young and adult spontaneously hypertensive rats.
    Cloutier F, Ongali B, Campos MM, Thibault G, Neugebauer W, Couture R.
    Br J Pharmacol; 2004 May 23; 142(2):285-96. PubMed ID: 15066903
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Down-regulation of brain and spinal cord K-opiate receptors in spontaneously hypertensive, Wistar-Kyoto normotensive, and Sprague-Dawley rats by chronic treatment with U-50, 488H.
    Bhargava HN, Gulati A, Ramarao P.
    Biochem Pharmacol; 1991 Jun 21; 42(1):25-9. PubMed ID: 1648922
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.